Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
The Future of Medicine is Predictive|Stephanie Campbell,General Partner,The Artemis Fund
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
General Partner at The Artemis Fund.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Global Economic Insights: Forecasting with Johanna Kyrklund of Schroders - Johanna Kyrklund | Group Chief Investment Officer, Schroders
00:10:00
A company's financial performance speaks the volumes|Clara Brenner,General Partner, Urban Innovation Fund
00:10:00
Tim Chen, CEO of NerdWallet, appears on 'Closing Bell Overtime' to discuss the company's new credit-building card, a significant stock surge, and more.|Tim Chen is the founder and CEO of NerdWallet.
00:10:00
Building a Vision: Turning Dreams into a Global Movement| Nir Bar Dea, CO-CEO , Bridgewater Associates LP.
00:10:00
Norse Inc: Advancing High-Grade Critical Minerals Project in NWT
00:10:00
Reflections on Education Leadership: Joel Klein's Journey|Joel Klein
00:00:00
Collagen Solutions released financial number showing more strong sales numbers - Jamal Rushdy, Chief Executive Office, Collagen Solutions
00:10:00
Birimian: Advancing Mali's Goulamina Lithium Project with Strong Resource Potential
00:10:00
Yuri Milner on Building DST Global and Investing in the Future | Yuri Milner, Founder, DST Global.
00:10:00
Taking Financial Reporting to the Cloud | John Lowe, CEO, CPI Card Group IncPMTS:NMQ
00:10:00
Maritime Resources Targets 2023 Production at Hammerdown Gold Project
00:10:00
Transforming Healthcare: Innovating Incentives for Better Outcomes | Andrew Toy, CEO, Clover Health Investments Corp.